Wuhan Low-dimensional Materials Research Institute Co., Ltd. announced that it has signed a capital increase agreement with Qianjiang Yongan Pharmaceutical Co., Ltd. (SZSE:002365) for a private placement to issue common shares to receive gross proceeds of CNY 10,000,000 on April 30, 2021. The proceeds of which CNY 292,400 will be included in the registered capital and the remaining CNY 9,707,600 will be included in the capital reserve. After the capital increase is completed, Qianjiang Yongan Pharmaceutical Co., Ltd. (SZSE:002365) will hold 5% equity stake in the company. The transaction has been approved at the 24th meeting of the 5th board of directors and do not need to be submitted to the shareholders meeting for deliberation.